Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluating low-intensity conditioning for allogeneic stem cell transplantation in multiple myeloma, chronic lymphocytic leuk…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade
This document notes the completion of an observational study assessing Velcade (bortezomib) in Chinese patients with multiple myeloma. The t…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 study evaluating cyclophosphamide as the sole graft-versus-host disease prophylaxis after allogeneic stem cell transplantation has c…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma [Phase 2]
Phase 2 trial results evaluating a triplet of bortezomib, lenalidomide, and dexamethasone in relapsed or relapsed/refractory multiple myelom…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
The clinical trial evaluating blood stem cell transplants in adults and children with various hematologic cancers, sponsored by Columbia Uni…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis [Phase 2]
Phase 2 trial evaluating pomalidomide (CC-4047) plus dexamethasone in relapsed or refractory multiple myeloma and amyloidosis; results have …
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 update on non-myeloablative allogeneic stem cell transplantation using mis-matched family donor cells purged with Campath (alemtuzum…
-
FDA approval · 2014-06-02FDA Approved: KYPROLIS — Supplemental Application (Onyx Pharmaceuticals, Inc.)
FDA approves a supplemental application for KYPROLIS (carfilzomib) from Onyx Pharmaceuticals. This action finalizes an update to KYPROLIS's …
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: PHA-739358 for the Treatment of Multiple Myeloma [Phase 2]
Phase 2 trial of PHA-739358 for multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 study of an allogeneic non-myeloablative stem cell transplant using matched family member donor cells purged with Campath (alemtuzum…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma. [Phase 1, Phase 2]
The study evaluated a conditioning regimen of melphalan and topotecan followed by autologous stem cell rescue in patients with multiple myel…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 3]
Phase 3 trial evaluating total-body irradiation with or without fludarabine phosphate followed by donor stem cell transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 trial of siltuximab (CNTO 328) in relapsed or refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants [Phase 1]
Phase 1 trial evaluating total body irradiation with fludarabine followed by combined umbilical cord blood transplants has completed. The tr…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma [Phase 2]
This clinical trial update notes the completion of a Phase 2 study assessing the efficacy and safety of siltuximab in relapsed or refractory…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma [Phase 2]
This Phase 2 trial evaluating the efficacy and safety of re-treatment with bortezomib in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS withdrawal · 2014-05-12Clinical Trial Update: Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM) [Phase 2]
A Phase 2 trial of SDX-101 (R-Etodolac) for relapsed or refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant [Phase 2]
Phase 2 study evaluating plerixafor to rescue poor mobilizers in autologous stem cell transplantation has completed; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [Phase 2]
A Phase 2 trial evaluating a conditioning regimen of total-body irradiation with tacrolimus and mycophenolate mofetil followed by bone marro…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating donor bone marrow transplantation for hematologic cancers has completed; the study enrolled patients with leukemia,…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating Interleukin-2 after bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone [Phase 3]
A phase 3 trial compared a triplet regimen of bortezomib, thalidomide, and dexamethasone to a bortezomib-dexamethasone doublet and to a bort…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study [Phase 3]
Phase 3 trial comparing pomalidomide plus low-dose dexamethasone to high-dose dexamethasone in refractory/relapsed multiple myeloma; study c…
-
CLINICAL_TRIALS research · 2014-04-28Clinical Trial Update: Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.
An observational study evaluating the effects of intravenous bortezomib on osteoblast activity in patients with multiple myeloma.